Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Myocardial Ischemia » Coronary Disease » Coronary Artery Disease
Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Arterial Occlusive Diseases » Arteriosclerosis » Coronary Artery Disease
Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Myocardial Ischemia » Coronary Disease » Coronary Artery Disease
Description
Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. MeSH
Hierarchy View
Approved Indicated Drugs (24)
Phase 2 Indicated Drugs (65)
Phase 1 Indicated Drugs (22)
Other Experimental Indicated Drugs (44)
Organization Involved with Phase 4 Indications (353)
Ada and Hagbart Waages Humanitarian and Charity Foundation
Alf and Aagot Helgesens Research Foundation
Allies in Cardiovascular Trials Initiatives and Organized
ANMCO Italian Association of Hospital Cardiologist
Applied Health Research Centre
Aristotle University of Thessaloniki
Associations for Establishment of Evidence in Interventions
Atlanta Heart Specialists, LLC
Bio-Inova Life Sciences International
Boryung Pharmaceutical Company
Cardiovascular Consultants of Nevada
Cardiovascular Imaging Technologies
Cardiovascular Institute of the South Clinical Research Corporation
Cardiovascular Research Center, Brazil
CardioVascular Research Foundation, Korea
Case Western Reserve University
Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland
Centro de estudios en Cardiologia Intervencionista
China Academy of Chinese Medical Sciences
Chinese Academy of Medical Sciences
Clinical Hospital Center Zemun
Cristália Produtos Químicos Farmacêuticos Ltda.
Daewoong Pharmaceutical Co. LTD.
D'Annunzio University of Chieti–Pescara
Federal University of Health Science of Porto Alegre
Fundação de Amparo à Pesquisa do Estado de São Paulo
German Federal Ministry of Education and Research
Guangdong Provincial Hospital of Traditional Chinese Medicine
Haugaard, Steen Bendix, M.D., DMSc
Heart and Stroke Foundation of Canada
Hospital Alessandro Manzoni Lecco
Hospital Italiano de Buenos Aires
Huazhong University of Science and Technology
Icahn School of Medicine at Mount Sinai
Imam Abdulrahman Bin Faisal University
I.M. Sechenov First Moscow State Medical University
Institute for Clinical Effectiveness, Japan
Institut National de la Santé Et de la Recherche Médicale, France
Instituto Dante Pazzanese de Cardiologia
Instituto Mexicano del Seguro Social
Instituto Nacional de Cardiologia Ignacio Chavez
Italian Society of Invasive Cardiology
Japan Cardiovascular Research Foundation
Jiangsu Kangyuan Pharmaceutical Co. Ltd
King Fahad Armed Forces Hospital
Kyoto Prefectural University of Medicine
Lepu Medical Technology (Beijing) Co., Ltd.
Liaoning Hospital of Traditional Chinese Medicine
Methodist Cancer Center, Houston, Texas
National Cheng Kung University
National Health and Medical Research Council, Australia
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Cardiology, Mexico City, Mexico.
National Institute of General Medical Sciences (NIGMS)
National Institute on Aging (NIA)
National Natural Science Foundation of China
Nova Scotia Health Research Foundation
Pauls Stradins Clinical University Hospital
People's Liberation Army of China
Phramongkutklao College of Medicine and Hospital
Platelet and Thrombosis Research L.L.C
Research Institute for Complex Problems of Cardiovascular Diseases, Russia
Samjin Pharmaceutical Co., Ltd.
Shanghai Hutchison Pharmaceuticals Limited
Shanghai MicroPort Medical (Group) Co., Ltd.
Shanghai Xuhui District Central Hospital
Shenzhen Salubris Pharmaceuticals Co., Ltd.
St. Antonius Hospital, Nieuwegein
St Joseph University of Beirut
Taipei Veteran General hospital
The Baruch Padeh Medical Center, Poriya
The Norwegian Council on Cardiovascular Disease
The University of Texas, Dallas
Ukrainian Medical Stomatological Academy
University Hospital of Limerick
University of British Columbia
University of California, Los Angeles
University of California, San Francisco
University of Campania Luigi Vanvitelli
University of Colorado, Denver
University of Modena and Reggio Emilia
University of Roma La Sapienza
University of Texas, San Antonio
Vita-Salute University of Milano. Italy
WanBangDe Pharmaceutical Group Co.,Ltd.
Organization Involved with Phase 3 Indications (152)
Advanced Accelerator Applications
Andalusian Initiative for Advanced Therapies
Andalusian Initiative in Advanced Therapies
Assistance Publique - Hôpitaux de Paris
Associazione Nazionale Medici Cardiologi Ospedalieri
Catharina Ziekenhuis Eindhoven
Catholic University of Sacred Heart, Rome
Centro Cardiológico del Caribe, Columbia
Dr. Negrin University Hospital
Foundation to Promote Research into Functional Vitamin B12 Deficiency, Bergen, Norway
Hamilton Health Sciences Corporation
IHF GmbH - Institut für Herzinfarktforschung
Institute of Cardiology, Warsaw, Poland
Juvenile Diabetes Research Foundation
Kerckoff clinic, Bad Nauheim, Germany
King Faisal Specialist Hospital
Mt. Sinai Medical Center, Miami
National Cancer Institute (NCI)
National Center for Complementary and Integrative Health (NCCIH)
National Heart Institute, Bach Mai Hospital, Vietnam
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Neurological Disorders and Stroke (NINDS)
Newmarket Electrophysiology Research Group Inc
Norwegian Heart and Lung Patient Organisation
Novosibirsk Research Institute of Circulation Pathology
Pontifícia Universidade Católica do Paraná
Prince Sultan Cardiac Center, Riyadh
Rajaie Cardiovascular Medical and Research Center
Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC)
Servicio de Evaluación. Servicio Canario de Salud. Spain
Shahid Beheshti University of Medical Sciences
SMT KASHIBAI NAVALE MEDICAL COLLEGE
Steno Diabetes Center Copenhagen
Translational Research Informatics Center, Kobe, Hyogo, Japan
Universidad del Norte, Barranquilla
University Hospital of North Norway
University of California, San Diego
University of Las Palmas de Gran Canaria
University of Rome Tor Vergata
University of Southern California
University of Western Brittany
Venezuelan Foundation of Heart Failure
Working Group Aterosclerosi, Trombosi e Biologia Vascolare
Zhejiang Hisun Pharmaceutical Co. Ltd.
ZonMw: The Netherlands Organisation for Health Research and Development
Organization Involved with Phase 2 Indications (119)
Canadian Anesthesiologists' Society
Cardiovascular Cell Therapy Research Network
Centre for Digestive Diseases, Australia
Changchun University of Chinese Medicine
Chengdu University of Traditional Chinese Medicines
Fundacion Investigacion y Desarrollo
German Center for Cardiovascular Research e. V. (DZHK)
Heart and stoke fondation of Quebec
Heilongjiang University of Traditional Chinese Medicine
Hellenic Cardiovascular Research Society
HonorHealth Research Institute
Hunan University of Traditional Chinese Medicine
Ivy Institute of Stem Cells Co. Ltd
Jacksonville Center for Clinical Research
Jiangsu vcare pharmaceutical technology co., LTD
Jilin Academy of Traditional Chinese Medicine
Katholieke Universiteit Leuven
National Institute of Mental Health (NIMH)
National Institutes of Health (NIH)
Papworth Hospital NHS Foundation Trust
Polpharma Foundation for Development of Polish Pharmacy and Medicine
Richardson Centre for Functional Foods and Nutraceuticals
Russian Academy of Medical Sciences
Shaanxi Buchang Pharmaceutical Co., Ltd
Shandong University of Traditional Chinese Medicine
South Australian Health and Medical Research Institute
St. Luke's-Roosevelt Hospital Center
Tallikut Pharmaceuticals, Inc.
Organization Involved with Phase 1 Indications (27)
Organization Involved with Other Experimental Indications (81)
Beijing Municipal Health Bureau
Canadian Collaborative Research Network
Chinese People's Armed Police Forces
Chinese University of Hong Kong
Conselho Nacional de Desenvolvimento Científico e Tecnológico
European Cardiovascular Research Center
Federal University of Rio de Janeiro
General Hospital of Chinese Armed Police Forces
Guangzhou University of Chinese Medicine
Henan Institute of Cardiovascular Epidemiology
Intermountain Research and Medical Foundation
James Cook University Hospital, Middlesbrough, UK
Klinički Bolnički Centar Zagreb
Maine Center for Lipids and Cardiovascular Health
National Center for Research Resources (NCRR)
National University of Ireland
New York City Health and Hospitals Corporation
NHS National Waiting Times Centre Board
Oregon Health and Science University
Rio de Janeiro State University
Saint Francis Memorial Hospital
Shaanxi Provincial People's Hospital
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
